| Detected | Trial | Change |
|---|---|---|
| 2026-08-04 | NCT07456046 A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With… |
Trial sites expanded: 5 -> 8 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT05410145 | A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid… | KRAS P.G12C | Recruiting |
| NCT05886920 | A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With… | Advanced Solid Tumors With MAPK Pathway Mutations | Recruiting |
| Phase 1 | |||
| NCT05957536 | A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors | HER-2 Positive Advanced Solid Tumors | Recruiting |
| NCT07456046 | A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With… | KRAS P.G12D | Recruiting |
| NCT07667842 | Study of D3L-002 in Subjects With Advanced Solid Tumors | Advanced Solid Tumor | Not Yet Recruiting |